英文論文
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
Keiji Nihei, Keiko Minashi, Tomonori Yano, Tadakazu Shimoda, Haruhiko Fukuda, Manabu Muto, JCOG-GIESG Investigators; Junki Mizuaswa, Kohei Takizawa, Ikuo Aoyama, Akiyoshi Ishiyama, Noboru Kawata, Daisuke Kikuchi, Noboru Hanaoka, Ichiro Oda, Yoshinori Morita , Masahiro Tajika, Junko Fujiwara, Yoshinobu Yamamoto, Chikatoshi Katada, Shinichiro Hori , Hisashi Doyama, Tsuneo Oyama, Hiroko Nebiki, Kenji Amagai, Yutaro Kubota, Yasuhiro Inokuchi, Nozomu Kobayashi, Takuto Suzuki, Kingo Hirasawa, Toshihisa Takeuchi, Tomohiro Kadota.
Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508
Gastroenterology. 2023 Feb;164(2):296-299.e2.
Tatsuya Ioka,Masashi Kanai,Shogo Kobayashi,Daisuke Sakai,Hidetoshi Eguchi,Hideo Baba,Satoru Seo,Akinobu Taketomi,Tadatoshi Takayama,Hiroki Yamaue,Masahiro Takahashi,Masayuki Sho,Keiko Kamei,Jiro Fujimoto,Masanori Toyoda,Junzo Shimizu,Takuma Goto,Yoshitaro Shindo,Kenichi Yoshimura,Etsuro Hatano,Hiroaki Nagano ,Kansai Hepatobiliary Oncology Group (KHBO)
Randomized phase III study of Gemcitabine, Cisplatin plus S-1 (GCS) versus Gemcitabine, Cisplatin (GC) for Advanced Biliary Tract Cancer (KHBO1401-MITSUBA).
J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110.
Yu Uneno ,Yasuhiro Kotera , Daisuke Fujisawa, Yuki Kataoka, Kazuhiro Kosugi, Nanami Murata, Takaomi Kessoku, Akihiko Ozaki, Hirotomo Miyatake, Manabu Muto.
Development of a novel COMPAssion focused online psyChoTherapy for bereaved informal caregivers: the COMPACT feasibility trial protocol.
BMJ Open.2022 Dec 22;12(12):e067187.
Masashi Kanai.
Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
Curr Oncol. 2022 Sep 30;29(10):7272-7284.
Takashi Murakami, Rihito Aizawa, Yukinori Matsuo, Hideki Hanazawa, Kojiro Taura, Akihisa Fukuda, Norimitsu Uza, Masahiro Shiokawa, Masashi Kanai, Etsuro Hatano, Hiroshi Seno, Manabu Muto, Takashi Mizowaki.
Efficacy and Safety of External-beam Radiation Therapy for Unresectable Primary or Local Recurrent Cholangiocarcinoma.
Cancer Diagn Progn. 2022 Nov 3;2(6):634-640.
Tomohiko Sunami, Atsushi Yamada, Tomohiro Kondo, Masashi Kanai, Kazuyuki Nagai, Yoichiro Uchida, Masataka Yokode, Tomoaki Matsumori, Norimitsu Uza, Hiromi Murakami, Takahiro Yamada, Manabu Muto.
Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.
Pancreas. 2022 Oct 1;51(9):1258-1262.
Yu Uneno, Haruki Imura, Yosuke Makuuchi, Kentaro Tochitani and Norio Watanabe.
Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.
Cochrane Database Syst Rev. 2022 Nov 28;11(11):CD013604.
Soichiro Okamoto, Yu Uneno, Natsuki Kawashima, Shunsuke Oyamada, Yusuke Hiratsuka, Keita Tagami, Manabu Muto, Tatsuya Morita.
Difficulties facing junior physicians and solutions toward delivering end-of-life care for patients with cancer: a nationwide survey in Japan.
Palliat Med Rep. 2022 Oct 27;3(1):255-263.
Tomoyuki Abe, Yoshihito Horisawa, Osamu Kikuchi, Hitomi Ozawa-Umeta, Atsuhiro Kishimoto, Yasuhiro Katsuura, Atsushi Imaizumi, Tadashi Hashimoto, Kotaro Shirakawa, Akifumi Takaori-Kondo, Kosuke Yusa, Tadashi Asakura, Hideaki Kakeya, Masashi Kanai.
Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin.
Eur J Pharmacol. 2022 Nov 15;935:175321.
Yoshihiro Yamamoto Keita Fukuyama, Masashi Kanai, Tomohiro Kondo, Masahiro Yoshioka, Tadayuki Kou, Pham Nguyen Quy, Reiko Kimura-Tsuchiya, Takahiro Yamada, Shigemi Matsumoto, Shinji Kosugi, Manabu Muto.
Prevalence of pathogenic germline variants in the circulating tumor DNA testing.
Int J Clin Oncol. 2022 Oct;27(10):1554-1561.